Skip to main content
SpringerLink
Log in

Systemische und rückenmarknahe Therapie mittels Schmerzpumpen und Ports

  • Chapter
Schmerzbehandlung in der Palliativmedizin

  • 3119 Accesses

Zusammenfassung

Bei schwer behandelbaren Krebsschmerzen, die auch unter Ausschöpfung aller enteralen und/oder transdermalen Optionen des WHO-Stufenschema nicht oder nur mit inakzeptablen Nebenwirkungen beherrschbar sind, stellen intravenöse, subkutane und vor allem rückenmarknahe Applikationswege guteunderfolgversprechende Alternativen dar [4, 6, 8, 12, 9, 20].Hierzu stehen neben externen, druckbetriebenen Einmalreservoirpumpen, vor allem externe, mikroprozessorgesteuerte, programmierbare Patienten-kontrollierte Pumpen (PCA-Pumpen), implantierbare Portsysteme für intravenösen, epiduralen oder intrathekalen Zugang sowie vollständig implantierbare gas- oder batteriebetriebene Pumpen (ausschließlich zur Intrathekalgabe) verschiedener Hersteller zurVerfügung. Insgesamt bleiben diese invasivenVerfahren wenigen Patienten vorbehalten und werden — abhängig von der Spezialisierung der jeweiligen Einrichtung — nur bei ca. 5%bis 10%der Tumorschmerzbehandlungen notwendig.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aldrete JA (1995) Epidural fibrosis after permanent catheter insertion and infusion. J Pain Symptom Manage 10: 624–631

    Article  PubMed  CAS  Google Scholar 

  2. Bedder MD, Burchiel K, Larson A (1991) Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage 6: 368–373

    Article  PubMed  CAS  Google Scholar 

  3. Coffey RJ, Burchiel K (2002) Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients. Neurosurgery 50: 78–86

    PubMed  Google Scholar 

  4. Cools HJ, Berkhout AM, De Bock GH (1996) Subcutaneous morphine infusion by syringe driver for terminally ill patients. Age Ageing 25: 206–208

    Article  PubMed  CAS  Google Scholar 

  5. Dahm P, Nitescu P, Appelgren L, Curelaru I (1998) Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: a comparison between the epidural and the intrathecal approach with externalized or implanted catheters and infusion pumps. Clin J Pain 14: 4–16

    Article  PubMed  CAS  Google Scholar 

  6. Deer T, Krames ES, Hassenbusch SJ, Burton A, Caraway D, Dupen S, Eisenach J, Erdek M, Grigsby E, Kim P, Levy R, Mc Dowell G, Mekhail N, Panchal S, Prager J, Rauck R, Saulino M, Sitzman T, Staats P, Stanton-Hicks M, Stearns L, Willis D, Witt W, Follet K, Huntoon M, Liem L, Rathmell J, Wallace M, Buchser E, Cousins M, Ver Donck A (2007) Polyanalgesic consensus conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 10(4): 300–328

    Article  PubMed  Google Scholar 

  7. Devulder J, Ghys L, Dhondt W, Rolly G (1994) Spinal analgesia in terminal care: risk versus benefit. J Pain Symptom Manage 9: 75–81

    Article  PubMed  CAS  Google Scholar 

  8. Drexel H, Dzien A, Spiegel RW, Lang AH, Breier C, et al (1989) Treatment of severe cancer pain by low-dose continuous subcutaneous morphine. Pain 36: 169–176

    Article  PubMed  CAS  Google Scholar 

  9. Eisenach JC, Rauck RL, Buzzanell C, Lysak SZ (1989) Epidural clonidine analgesia for intractable cancer pain: Phase I. Anesthesiology 71: 647–652

    Article  PubMed  CAS  Google Scholar 

  10. Eisenach JC, Du Pen S, Dubois M, Miguel R, Allin D (1995) Epidural clonidine analgesia for intractable cancer pain. Pain 61: 391–399

    Article  PubMed  CAS  Google Scholar 

  11. Hassenbusch S, Burchiel K, Coffey RJ, Cousins MJ, Deer T, Hahn MB, Pen SD, Follett KA, Krames E, Rogers JN, Sagher O, Staats PS, Wallace M, Willis KD (2002) Management of intrathecal catheter-tip inflammatory masses: a consensus statement. Pain Med 3: 313–323

    Article  PubMed  Google Scholar 

  12. Hogan Q, Haddox JD, Abram S, Weissman D, Taylor ML, Janjan N (1991) Epidural opiates and local anesthetics for the management of cancer pain. Pain 46: 271–279

    Article  PubMed  CAS  Google Scholar 

  13. Iida H, Ohata H, Iida M, Nagase K, Uchida M, Dohi S (2001) The differential effects of stereoisomers of ropivacaine and bupivacaine on cerebral pial arterioles in dogs. Anesth Analg 93(6): 1552–1556

    Article  PubMed  CAS  Google Scholar 

  14. Krames ES (1993) Intrathecal infusional therapies for intractable pain: patient management guidelines. J Pain Symptom Manage 8: 36–46

    Article  PubMed  CAS  Google Scholar 

  15. Kress HG, Simpson KH, Marchettini P, Ver Donck A, Varrassi G (2009) Intrathecal therapy: what has changed with the introduction of ziconotide. Pain Pract 9: 338–47

    Article  PubMed  Google Scholar 

  16. Lanning RM, Hrushesky WJM (1990) Cost comparison of wearable and implantable drug delivery systems. Proc ASCO 9: 322

    Google Scholar 

  17. McMillan MR, Doud T, Nugent W (2003) Catheter-associated masses in patients receiving intrathecal analgesic therapy. Anesth Analg 96: 186–190

    PubMed  Google Scholar 

  18. Müller H (2001) Spinale Opioidanalgesie. In: Zenz M, Jurna I (Hrsg) Lehrbuch der Schmerztherapie. Wissenschaftliche Verlagsges, Stuttgart, S 441–456

    Google Scholar 

  19. Nitescu P, Appelgren L, Hultman E, Lindner LE, Sjoberg M, Curelaru I (1991) Longterm, open catheterization of the spinal subarachnoid space for continuous infusion of narcotic and bupivacaine in patients with „refractory“ cancer pain. Clin J Pain 7: 143–161

    Article  PubMed  CAS  Google Scholar 

  20. Patt RB (ed) (1993) Cancer pain. Lippincott, Philadelphia, pp 329–341

    Google Scholar 

  21. Samuelsson H, Malmberg F, Eriksson M, Hedner T (1995) Outcomes of epidural morphine treatment in cancer pain: nine years of clinical experience. J Pain Symptom Manage 10: 105–112

    Article  PubMed  CAS  Google Scholar 

  22. Sator-Katzenschlager S, Deusch E, Maier P, Spacek A, Kress HG (2001) The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance. Anesth Analg 93: 1032–1034

    Article  PubMed  CAS  Google Scholar 

  23. Sjoberg M, Nitescu P, Appelgren L, Curelaru I (1994) Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Anesthesiology 80: 284–297

    Article  PubMed  CAS  Google Scholar 

  24. Smith DE (1990) Spinal opioids in the home and hospice setting. J Pain Symptom Manage 5: 175–182

    Article  PubMed  CAS  Google Scholar 

  25. Vranken JH, Troost D, Wegener JT, Kruis MR, van der Vegt MH (2005) Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain. Pain 117(1–2): 813–818

    Google Scholar 

  26. Waldmann CS, Eason JR, Rambohul E, Hanson GC (1984) Serum morphine levels. A comparison between continuous subcutaneous infusion and continuous intravenous infusion in postoperative patients. Anaesthesia 39: 768–771

    Article  PubMed  CAS  Google Scholar 

  27. Yaksh TL (1996) Intrathecal and epidural opiates: a review. In: Campbell JN (ed) Pain 1996 — an updated review. IASP Press, Seattle, S 381–393

    Google Scholar 

  28. Yaksh TL, Hassenbusch S, Burchiel K, Hildebrand KR, Page LM, Coffey RJ (2002) Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med 3: 300–312

    Article  PubMed  Google Scholar 

  29. Yaksh TL, Horais KA, Tozier NA, Allen JW, Rathbun M, Rossi SS, Sommer C, Meschter C, Richter PJ, Hildebrand KR (2003) Chronically infused intrathecal morphine in dogs. Anesthesiology 99: 174–187

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Hans Georg Kress
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Birgit Kraft
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Naturwissenschaftliche Fakultät, Fachbereich für Organismische Biologie, Arbeitsgruppe für „Neurodynamics und Neurosignaling“, Universität Salzburg, Hellbrunner Straße 34, 5020, Salzburg, Österreich

    Günther Bernatzky

  2. Schmerzzentrum, Universitätsklinikum Erlangen, Krankenhausstraße 12, 91054, Erlangen, Deutschland

    Reinhard Sittl

  3. Anästhesie und Intensivmedizin, Klinikum Klagenfurt am Wörthersee, Feschnigstraße 11, 9020, Klagenfurt, Österreich

    Rudolf Likar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag/Wien

About this chapter

Cite this chapter

Kress, H.G., Kraft, B. (2012). Systemische und rückenmarknahe Therapie mittels Schmerzpumpen und Ports. In: Bernatzky, G., Sittl, R., Likar, R. (eds) Schmerzbehandlung in der Palliativmedizin. Springer, Vienna. https://doi.org/10.1007/978-3-211-88877-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-88877-3_16

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-88876-6

  • Online ISBN: 978-3-211-88877-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation